China approves Eli Lilly's weight-loss pill orforglipron
China has approved orforglipron, Eli Lilly's weight-loss pill, Reuters and Handelsblatt report. Global Times calls it the first oral GLP-1 weight-loss drug approved by China.
Narrative thread · 1 event
China has approved Eli Lilly's weight-loss pill orforglipron, according to Reuters and Handelsblatt. Chinese state-run Global Times calls it the first oral GLP-1 weight-loss drug approved in the country.
GLP-1 drugs, which curb appetite and lower blood sugar, have become a major global market for obesity and diabetes treatment. Western drugmakers such as Eli Lilly compete for access to China, where regulators must approve each product before sale.
China has approved orforglipron, Eli Lilly's weight-loss pill, Reuters and Handelsblatt report. Global Times calls it the first oral GLP-1 weight-loss drug approved by China.